PAVmed (PAVM) Notes Payables (2020 - 2021)
PAVmed's quarterly Notes Payables came in at $300000.0 in Q1 2021, little changed quarter-over-quarter from $300000.0 in Q4 2020.
PAVmed has reported Notes Payables for 2 years, with the latest figure at $300000.0 in Q1 2021.
- For the quarter ending Q1 2021, Notes Payables changed N/A year-over-year to $300000.0; the trailing twelve-month figure through Mar 2021 stood at $300000.0 (changed N/A YoY), and the FY2020 full-year result was $300000.0, changed N/A from the prior year.
- Notes Payables for Q1 2021 stood at $300000.0, roughly flat from $300000.0 in the prior quarter.
- The five-year high for Notes Payables was $300000.0 in Q4 2020, with the low at $150000.0 in Q2 2020.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | PAVmed | 4.15 Mn | -9.02 Mn | -703,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2021 | 300,000.00 |
| Dec 31, 2020 | 300,000.00 |
| Sep 30, 2020 | 200,000.00 |
| Jun 30, 2020 | 150,000.00 |